Angeles Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$734K Buy
17,202
+10,053
+141% +$546K 0.03% 203
2026
Q1
$449K Buy
7,149
+721
+11% +$57.7K 0.02% 253
2025
Q4
$613K Buy
6,428
+965
+18% +$94.6K 0.03% 180
2025
Q3
$533K Buy
5,463
+480
+10% +$49.7K 0.03% 180
2025
Q2
$535K Buy
4,983
+617
+14% +$62.4K 0.04% 177
2025
Q1
$440K Buy
4,366
+1,000
+30% +$101K 0.04% 153
2024
Q4
$301K Buy
3,366
+415
+14% +$36.5K 0.02% 210
2024
Q3
$247K Buy
+2,951
New +$233K 0.02% 234

Other funds holding BSX

Angeles Wealth Management's BSX Position: Q2 2026 in Review

Angeles Wealth Management increased its Boston Scientific (BSX) stake by 141% in Q2 2026, buying an estimated $546K and bringing the position to 17,202 shares worth $734K. The position accounts for 0.03% of the portfolio, ranked #203.

Angeles Wealth Management first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Angeles Wealth Management held 17,202 shares of Boston Scientific worth $734K as of Q2 2026.
  • Angeles Wealth Management bought 10,053 Boston Scientific shares in Q2 2026, an estimated $546K.
  • Boston Scientific made up 0.03% of Angeles Wealth Management's portfolio in Q2 2026, its #203 holding.
  • Angeles Wealth Management first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.